Luigi Grasso
Fondatore presso Navrogen, Inc.
Posizioni attive di Luigi Grasso
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Navrogen, Inc.
 Navrogen, Inc. Pharmaceuticals: MajorHealth Technology Navrogen, Inc. is a biotechnology company, which engages in the discovery and development of tumor produced HIO-factors that are associated with cancer prognosis and therapeutic response of immune-mediated anti-cancer therapies. The company was founded by Luigi Grasso and Nicholas C. Nicolaides in 2017 and is headquartered in Philadelphia, PA. | Direttore/Membro del Consiglio | 01/01/2017 | - |
| Direttore Tecnico/Scientifico/R&S | 01/01/2017 | - | |
| Fondatore | 01/01/2017 | - |
Storia della carriera di Luigi Grasso
Precedenti posizioni note di Luigi Grasso
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Morphotek, Inc.
 Morphotek, Inc. Miscellaneous Commercial ServicesCommercial Services Morphotek, Inc. operates as a biotechnology company. It develops and distributes biopharmaceutical products. The firm leverages its Morphodoma and Libradoma platform technologies to develop and research a pipeline of preclinical and clinical stage monoclonal antibodies for the treatment of cancer, inflammation and infectious diseases. The company was founded by Nicholas C. Nicolaides, Luigi Grasso and Philip M. Sass in May 2000 and is headquartered in Exton, PA. | Direttore Tecnico/Scientifico/R&S | 01/05/2000 | 01/04/2018 |
| Fondatore | 23/02/2011 | 01/04/2018 |
Formazione di Luigi Grasso
| University of Catania | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
| Italia | 2 |
Posizioni
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 2 |
| Doctorate Degree | 1 |
Settori
| Commercial Services | 2 |
| Consumer Services | 2 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 2 |
|---|---|
Morphotek, Inc.
Morphotek, Inc. Miscellaneous Commercial ServicesCommercial Services Morphotek, Inc. operates as a biotechnology company. It develops and distributes biopharmaceutical products. The firm leverages its Morphodoma and Libradoma platform technologies to develop and research a pipeline of preclinical and clinical stage monoclonal antibodies for the treatment of cancer, inflammation and infectious diseases. The company was founded by Nicholas C. Nicolaides, Luigi Grasso and Philip M. Sass in May 2000 and is headquartered in Exton, PA. | Commercial Services |
Navrogen, Inc.
Navrogen, Inc. Pharmaceuticals: MajorHealth Technology Navrogen, Inc. is a biotechnology company, which engages in the discovery and development of tumor produced HIO-factors that are associated with cancer prognosis and therapeutic response of immune-mediated anti-cancer therapies. The company was founded by Luigi Grasso and Nicholas C. Nicolaides in 2017 and is headquartered in Philadelphia, PA. | Health Technology |
- Borsa valori
- Insiders
- Luigi Grasso
- Esperienza
